DCPH News and Press, Deciphera Pharmaceuticals Inc. From 04/29/24

2024-04-29 07:52:23 ET Deciphera Pharmaceuticals ( NASDAQ: DCPH ) announced on Monday that Japan’s ONO Pharmaceutical has agreed to acquire the cancer drug developer for a total equity value of $2.4B.... Read the full article on Seeking Alpha For further detai...

Deciphera Shareholders to Receive $25.60 per Share in Cash Deciphera’s Kinase Inhibitor Expertise and Established Commercialization Platform in Key Markets Will Reinforce ONO Pharmaceutical’s Pipeline and Accelerate Global Reach Deciphera Pharmaceuticals, Inc. (NAS...

2024-04-26 15:56:40 ET Summary Shares of Deciphera Pharmaceuticals, Inc. have rallied 40% since October after positive trial data for vimseltinib in the treatment of TGCT. Vimseltinib is expected to make significant progress in the TGCT indication, as the only approved therapy is ...

2024-04-25 17:49:16 ET Summary The Annual Meeting of the American Society of Clinical Oncology is a major event for clinicians and researchers in the field of oncology. The plenary session will feature presentations on topics such as esophageal cancer, melanoma, and lung cancer. ...

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that members of the management team will participate in a fireside chat at the St...

2024-03-21 19:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-03-11 17:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-03-10 13:08:00 ET More on ALX Oncology, Bicycle Therapeutics, etc. Immunocore Holdings plc (IMCR) Q4 2023 Earnings Call Transcript Kura Oncology, Inc. (KURA) Q4 2023 Earnings Call Transcript Kura Oncology, Inc. 2023 Q4 - Results - Earnings Call Presentation ...

2024-02-06 16:00:07 ET Deciphera Pharmaceuticals, Inc. (DCPH) Q4 2023 Earnings Conference Call February 06, 2024, 08:00 AM ET Company Participants Jen Larson - SVP, Finance and IR Steve Hoerter - President and CEO Matt Sherman - Chief Medical Officer Dan Mart...

2024-02-06 07:01:46 ET More on Deciphera Pharmaceuticals Deciphera: Upside Potential For The Patient Investor Deciphera Pharmaceuticals: Moving The Needle Where It Counts Deciphera forges exclusive distribution deal with Genesis Pharma Seeking Alpha’s ...